Article

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A…

International Journal of Chronic Obstructive Pulmonary Disease · 2021 · Martin C, Burgel PR, Roche N

Key facts

Title Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
First author Martin C, Burgel PR, Roche N
Journal International Journal of Chronic Obstructive Pulmonary Disease
Published Aug 16, 2021
DOI 10.2147/COPD.S226688
Devices mentioned 200411, 204644, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 3 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature